Toronto (ots/PRNewswire) - Bank of Montreal (TSX: BMO)(NYSE: BMO) today announced that the Board of Directors declared a quarterly dividend of $0.90 per share on paid-up common shares of Bank of Montreal for the third quarter of fiscal year 2017 ("Q3 2017 Dividend"), a 2 cent increase from the previous quarter and up 5% from a year ago. The Board of Directors also declared dividends of: - $0.211875 per share on paid-up ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: AEVIS VICTORIA SA accepts BioTelemetry's revised offer 24-May-2017 / 11:26 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 577035 24-May-2017 CET/CEST ...
issuer: OMV Aktiengesellschaft Trabrennstraße 6-8 A-1020 Wien phone: +43 1 40440/21600 FAX: +43 1 40440/621600 mail: investor.relations@omv.com WWW: http://www.omv.com ISIN: AT0000743059 indexes: ATX stockmarkets: Wien language: English ...
SCHOELLER-BLECKMANN OILFIELD EQUIPMENT Aktiengesellschaft
issuer: Schoeller-Bleckmann Oilfield Equipment AG Hauptstrasse 2 A-2630 Ternitz phone: 02630/315110 FAX: 02630/315101 mail: sboe@sbo.co.at WWW: http://www.sbo.at ISIN: AT0000946652 indexes: ATX, WBI stockmarkets: Wien language: English ...
Lausanne, Switzerland and Waltham, Mass. (ots) - Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGen's focus on strategic growth initiatives and generates near-term value Debiopharm International SA ...
issuer: UNIQA Insurance Group AG Untere Donaustraße 21 A-1029 Wien phone: 01/211 75-0 FAX: mail: investor.relations@uniqa.at WWW: http://www.uniqagroup.com ISIN: AT0000821103 indexes: ATX, WBI stockmarkets: Wien language: English ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry announces increase of price in its public offer for LifeWatch 24-May-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576859 24-May-2017 CET/CEST ...
London (ots/PRNewswire) - Award recognizes Reliance Jio and Accedian's collaboration on nationwide deployment of virtualized network monitoring solution Accedian (https://accedian.com/), the end-to-end network performance expert, and Reliance Jio, the ground-breaking 4G greenfield operator in India, have won a Global Telecoms Business Innovation Award, in the ...
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer AEVIS VICTORIA SA tenders shares into BioTelemetry's revised takeover offer for LifeWatch Ltd 24-May-2017 / 06:33 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576863 24-May-2017 CET/CEST ...
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Miscellaneous Leclanché SA: Leclanché update on fire at corporate headquarters in Switzerland on 22 May 23-May-2017 / 18:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576819 23-May-2017 CET/CEST ...
Calgary, Alberta (ots/PRNewswire) - Nature Reviews Nephrology and Pfizer Inc. discuss BET bromodomain inhibition and apabetalone as viable drug candidates Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today highlighted two additional works involving its lead drug, apabetalone, one recently published ...
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): AGM/EGM AEVIS VICTORIA SA - General Meeting of Shareholders of 13 June 2017 23-May-2017 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576073 23-May-2017 CET/CEST ...
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer AEVIS VICTORIA SA publishes a supplement No 5 to the prospectus of its public takeover offer for LifeWatch Ltd. 23-May-2017 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576295 23-May-2017 CET/CEST ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer LifeWatch AG: BioTelemetry, Inc. announces extension of the main offer period for public offer for LifeWatch AG 22-May-2017 / 23:11 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576305 22-May-2017 CET/CEST ...
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Miscellaneous Leclanché SA: Fire at Leclanché's offices extinguished. All staff are safe. Alternative business continuity plan is being implemented. 22-May-2017 / 18:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 576259 22-May-2017 CET/CEST ...
Karlsruhe (ots) - New project awards to Cinemo further cement the relationship with Alpine in developing seamless next generation in-car entertainment Cinemo, a global leader in high performance and automotive grade multimedia playback, streaming, media management and connectivity middleware, has announced they will be working with Alpine Electronics Inc., a premier ...
Ballerup, Denmark (ots/PRNewswire) - Opinion from CHMP: "On 18 May 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product [brodalumab], intended for the treatment of psoriasis[...]The benefits with ...
Zurich (ots) - Zürcher Kantonalbank is calling the Additional Tier 1 bond with a notional amount of CHF 590 million as of 30 June 2017 and intends to issue a new Additional Tier 1 bond. Zürcher Kantonalbank is today announcing the redemption of its ...
Ballerup, Denmark (ots/PRNewswire) - Opinion from CHMP: "On 18 May 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product [brodalumab], intended for the treatment of psoriasis[...]The benefits with ...
Lyon, France and Boston (ots/PRNewswire) - Mérieux Développement has recently concluded an equity investment into Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of injectable drugs. With this additional financing, Xeris Pharmaceuticals expects to fund registration trials and ...
issuer: C-QUADRAT Investment AG Schottenfeldgasse 20 A-1070 Wien phone: +43 1 515 66-0 FAX: +43 1 515 66-159 mail: c-quadrat@investmentfonds.at WWW: www.c-quadrat.com ISIN: AT0000613005 indexes: stockmarkets: Wien, Frankfurt language: English ...
JTI Japan Tobacco International AG
Brussels (ots/PRNewswire) - From May 20, tobacco products placed on the market in EU countries will have to comply with the Tobacco Products Directive (TPD2), a raft of draconian rules that will impact consumers and businesses across the Union without meeting its intended goals. (Logo: http://photos.prnewswire.com/prnh/20130528/617491 ) "This is yet another example of ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - New clinical and real-life data in chronic hypoparathyroidism, to advance understanding of this rare disease and improve patients' lives Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, announced today new research to be presented on rhPTH(1-84) and on the ...
DGAP-Ad-hoc: LION E-Mobility AG / Key word(s): Investment/Miscellaneous LION E-Mobility AG: LION E-Mobility AG invests in Inboard Technology 18-May-2017 / 19:21 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...
National Cancer Centre Singapore (NCCS) and Singapore Clinical Research Institute (SCRI)
Singapore (ots/PRNewswire) - The SIRveNIB abstract published on-line in the Journal of Clinical Oncology states that treatment of locally advanced Hepatocellular Carcinoma (HCC) with a single treatment of SIR-Spheres® Y-90 resin microspheres results in Overall Survival not significantly different from twice-daily ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - - Study met primary endpoint demonstrating significantly greater remission rates in patients receiving anti-MAdCAM antibody (SHP647) compared to placebo in three of four tested dose groups - First study to investigate the potential role of anti-MAdCAM antibody in the management of ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - - Significant reduction in monthly Hereditary Angioedema (HAE) attack rate with infrequent subcutaneous administration - Data to serve as basis for U.S. BLA filing expected in Q4 2017 to Q1 2018 - Shire to host Investor Call today at 10 a.m. ET; details below Shire plc ...
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer AEVIS VICTORIA SA: Integration of Clinique des Tilleuls in Swiss Medical Network 18-May-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 574867 18-May-2017 CET/CEST ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or U.S.-based media ASCO Abstract # M7824 (anti-PD-L1/TGF-ß trap): 3006; Avelumab: 9086, 9530, 9557, 4528, 3059, 5037, e21070, e21065, e20581; Tepotinib: 4087, 8547, e15676, 20541; M3814 (DNA-PK): 2556, e14048; M7583 (BTKi): e14101 - ASCO data highlights ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - A total of 13 abstracts across seven hard-to-treat cancers highlight the progress of avelumab as a monotherapy and potential novel combination treatment option - New data in metastatic Merkel cell carcinoma and ...